Topic: Sovereign Collateral

Pfizer is accused of demanding extreme concessions from national governments in exchange for vaccine supplies, including immunity from negligence lawsuits. In Argentina, the company reportedly requested sovereign assets—such as bank reserves, military bases, and embassy buildings—as collateral. This aggressive business posture is contrasted with the situation in Israel, where Pfizer secured an exclusive deal to use the entire population as a data set.